83 related articles for article (PubMed ID: 29454148)
1.
Sivapackiam J; Laforest R; Sharma V
Nucl Med Biol; 2018 Apr; 59():29-35. PubMed ID: 29454148
[TBL] [Abstract][Full Text] [Related]
2. (67/68)Galmydar: A metalloprobe for monitoring breast cancer resistance protein (BCRP)-mediated functional transport activity.
Sivapackiam J; Harpstrite SE; Prior JL; Mattingly S; Sharma V
Nucl Med Biol; 2016 Mar; 43(3):191-7. PubMed ID: 26924499
[TBL] [Abstract][Full Text] [Related]
3. Fluselenamyl: Evaluation of radiation dosimetry in mice and pharmacokinetics in brains of non-human primate.
Sundaram GSM; Jones L; Zhou Y; Laforest R; Sharma V
Nucl Med Biol; 2020; 82-83():33-40. PubMed ID: 31891882
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity.
Sivapackiam J; Kabra S; Speidel S; Sharma M; Laforest R; Salter A; Rettig MP; Sharma V
PLoS One; 2019; 14(5):e0215579. PubMed ID: 31120912
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.
Pfob CH; Ziegler S; Graner FP; Köhner M; Schachoff S; Blechert B; Wester HJ; Scheidhauer K; Schwaiger M; Maurer T; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1962-70. PubMed ID: 27207281
[TBL] [Abstract][Full Text] [Related]
6. [(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis.
Haubner R; Finkenstedt A; Stegmayr A; Rangger C; Decristoforo C; Zoller H; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2005-13. PubMed ID: 27164900
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
[TBL] [Abstract][Full Text] [Related]
8. Acute Rodent Tolerability, Toxicity, and Radiation Dosimetry Estimates of the S1P1-Specific Radioligand [
Liu H; Laforest R; Gu J; Luo Z; Jones LA; Gropler RJ; Benzinger TLS; Tu Z
Mol Imaging Biol; 2020 Apr; 22(2):285-292. PubMed ID: 31165387
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
Herrmann K; Lapa C; Wester HJ; Schottelius M; Schiepers C; Eberlein U; Bluemel C; Keller U; Knop S; Kropf S; Schirbel A; Buck AK; Lassmann M
J Nucl Med; 2015 Mar; 56(3):410-6. PubMed ID: 25698782
[TBL] [Abstract][Full Text] [Related]
10.
Ebenhan T; Sathekge MM; Lengana T; Koole M; Gheysens O; Govender T; Zeevaart JR
J Nucl Med; 2018 Feb; 59(2):334-339. PubMed ID: 29051342
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.
Sandström M; Lindskog K; Velikyan I; Wennborg A; Feldwisch J; Sandberg D; Tolmachev V; Orlova A; Sörensen J; Carlsson J; Lindman H; Lubberink M
J Nucl Med; 2016 Jun; 57(6):867-71. PubMed ID: 26912439
[TBL] [Abstract][Full Text] [Related]
12. Preliminary results of biodistribution and dosimetric analysis of [
Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.
Scheinin NM; Tolvanen TK; Wilson IA; Arponen EM; Någren KA; Rinne JO
J Nucl Med; 2007 Jan; 48(1):128-33. PubMed ID: 17204709
[TBL] [Abstract][Full Text] [Related]
15. Primary radiation dosimetry of a novel PET radiopharmaceutical
Cheki M; Gali H
Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263
[TBL] [Abstract][Full Text] [Related]
16. Safety, Biodistribution, and Radiation Dosimetry of
Nicolas GP; Beykan S; Bouterfa H; Kaufmann J; Bauman A; Lassmann M; Reubi JC; Rivier JEF; Maecke HR; Fani M; Wild D
J Nucl Med; 2018 Jun; 59(6):909-914. PubMed ID: 29025985
[TBL] [Abstract][Full Text] [Related]
17. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
[TBL] [Abstract][Full Text] [Related]
20. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest.
Maddahi J; Czernin J; Lazewatsky J; Huang SC; Dahlbom M; Schelbert H; Sparks R; Ehlgen A; Crane P; Zhu Q; Devine M; Phelps M
J Nucl Med; 2011 Sep; 52(9):1490-8. PubMed ID: 21849402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
